<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>PLOS Medicine | Open Source Toolkit</title><link>https://amchagas.github.io/open-source-toolkit/tag/plos-medicine/</link><atom:link href="https://amchagas.github.io/open-source-toolkit/tag/plos-medicine/index.xml" rel="self" type="application/rss+xml"/><description>PLOS Medicine</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>CC BY SA 4.0</copyright><lastBuildDate>Tue, 18 Apr 2017 00:00:00 +0000</lastBuildDate><image><url>https://amchagas.github.io/open-source-toolkit/media/openneuroscience_logo_dark.svg</url><title>PLOS Medicine</title><link>https://amchagas.github.io/open-source-toolkit/tag/plos-medicine/</link></image><item><title>An open source pharma roadmap</title><link>https://amchagas.github.io/open-source-toolkit/post/an_open_source_pharma_roadmap_plos_medicine/</link><pubDate>Tue, 18 Apr 2017 00:00:00 +0000</pubDate><guid>https://amchagas.github.io/open-source-toolkit/post/an_open_source_pharma_roadmap_plos_medicine/</guid><description>&lt;p>Publishing date: 2017-04-18&lt;/p>
&lt;p>Published on: PLOS Medicine&lt;/p>
&lt;p>summary: Editors note: This paper offers ideas and suggestion for new and open source ways of developing drugs and treatments. The idea is to rely on the open source philosophy and have companies/non-profits/academics/government working together in an open setting.&lt;/p>
&lt;p>authors: Manica Balasegaram, Peter Kolb, John McKew, Jaykumar Menon, Piero Olliaro, Tomasz Sablinski, Zakir Thomas, Matthew H. Todd , Els Torreele, John Wilbanks&lt;/p>
&lt;p>link to paper: 10.1371/journal.pmed.1002276&lt;/p>
&lt;p>Icons made by &lt;a href="https://www.flaticon.com/free-icon/bookshelves_3576884" title="catkuro">catkuro&lt;/a> from &lt;a href="https://www.flaticon.com/" title="Flaticon"> &lt;a href="http://www.flaticon.com">www.flaticon.com&lt;/a>&lt;/a>&lt;/p></description></item></channel></rss>